Fibrinolysis [phsf]
Lipoprotein (a) [aapp, bacs]
Women [popg]
coronary artery disease [dsyn]
influential [idcn]
Hormone replacement therapy [topp]
Background [cnce]
objectives [inpr]
Incidence [qnco]
coronary artery disease [dsyn]
GAD [mobd]
High [qlco]
Post-Menopause [orgf]
Pre-Menopause [phsf]
Women [popg]
Epidemiological Studies [resa]
Suggest [idcn]
Hormone replacement therapy [topp]
Decrease [qlco]
Risk [qlco]
Cardiovascular disease [dsyn]
Post-Menopause [orgf]
Women [popg]
Hormone replacement therapy [topp]
MODIFY [ftcn]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Several [qnco]
Mechanisms [ftcn]
Including [ftcn]
Modification [ftcn]
fibrinolytic [topp]
System [ftcn]
Lipoprotein (a) [aapp, bacs]
Level [qlco]
Study [mnob]
Aim [idcn]
investigating [ftcn]
Modification [ftcn]
Design [acty]
Methods [inpr]
cross sections [spco]
Part [spco]
Study [mnob]
Evaluated [ftcn]
Several [qnco]
Components [mnob]
fibrinolytic [topp]
System [ftcn]
Coagulation [ortf]
inhibitors [chvf]
Lipid [lipd]
Profile [lbpr]
premenopausal [tmco]
N NOS [aapp, imft]
Post-Menopause [orgf]
Women [popg]
N NOS [aapp, imft]
Compared [acty]
Parameters [fndg]
Health [idcn]
Pre-Menopause [phsf]
N NOS [aapp, imft]
Post-Menopause [orgf]
Women [popg]
N NOS [aapp, imft]
prospective [resa]
Part [spco]
Study [mnob]
Analyzed [resa]
Effect [qlco]
Hormone replacement therapy [topp]
transdermal estrogen [horm, phsu, strd]
Progestagen [horm, phsu, strd]
Post-Menopause [orgf]
Women [popg]
Result [ftcn]
Pre [tmco]
postmenopausal [tmco]
Women [popg]
Show [inpr]
Lower [spco]
fibrinolytic [topp]
activity [dora]
High [qlco]
Levels [qlco]
Control Groups [grup]
Lp(a) [aapp, bacs]
Level [qlco]
High [qlco]
Pre-Menopause [phsf]
Women [popg]
Health [idcn]
Pre-Menopause [phsf]
Women [popg]
Post-Menopause [orgf]
Women [popg]
Hormone replacement therapy [topp]
Induced [ftcn]
Decrease [qlco]
Lp(a) [aapp, bacs]
Level [qlco]
Observed [ftcn]
Parameter [spco]
Study [mnob]
Group [idcn]
treated [topp]
transdermal estrogen [horm, phsu, strd]
Progestagen [horm, phsu, strd]
Interpretation [inpr]
Conclusions [idcn]
Associated [qlco]
Decrease [qlco]
fibrinolytic [topp]
activity [dora]
Possibly [qlco]
Increase [ftcn]
Levels [qlco]
Increase [ftcn]
fibrinolytic [topp]
activity [dora]
Decrease [qlco]
Lp(a) [aapp, bacs]
Level [qlco]
Observed [ftcn]
Women [popg]
Receive [qlco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Favorable [qlco]
IMPACT [gngm]
Risk [qlco]
New [tmco]
cardiovascular events [fndg]
Post-Menopause [orgf]
Women [popg]
[c] [qnco]
Foundation [orgt]
